UVA Cancer Center | Strategic Alliance Partners

December 04, 2020

Firas El Chaer, MD, discusses the role of next-generation sequencing (NGS) in myeloproliferative neoplasms.

November 25, 2020

Firas El Chaer, MD, discusses the potential utility of combination strategies with ruxolitinib in patients with myeloproliferative neoplasms.

November 19, 2020

Emily C. Ayers, MD, discusses recent developments in chronic lymphocytic leukemia.

November 19, 2020

Kirsten ​L. Greene, MD, MAS, FACS, discusse​s the future of personalized therapy in prostate cancer.

November 17, 2020

Firas El Chaer, MD, discusses the limitations of JAK inhibitors in myelofibrosis.

April 21, 2020

Although the standard of care for muscle-invasive bladder cancer is well established, not enough patients are being treated with curative intent.